ITeos Therapeutics Company
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
Investors
Technology:
Biotechnology, Health Care, Medical
Industry:
End-to-end Drug Development
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2011-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
17
Total Funding:
249739241
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-04-01
Last Funding Type:
Series B
Register and Claim Ownership